XML 46 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   135,965,918      
Beginning balance at Dec. 31, 2022 $ 1,042,430 $ 1,686 $ 2,018,617 $ (6,886) $ (970,987)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances under equity incentive plans (in shares)   1,232,526      
Issuances under equity incentive plans 17,820 $ 12 17,808    
Vesting of restricted stock units (in shares)   1,187,054      
Vesting of restricted stock units 0 $ 13 (13)    
Stock-based compensation 108,399   108,399    
Net loss (145,224)       (145,224)
Other comprehensive income (loss) 7,529     7,529  
Ending balance (in shares) at Dec. 31, 2023   138,385,498      
Ending balance at Dec. 31, 2023 1,030,954 $ 1,711 2,144,811 643 (1,116,211)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)   3,244,689      
Issuance of common stock and pre-funded warrants, net of issuance costs 499,253 $ 32 499,221    
Issuances under equity incentive plans (in shares)   1,288,609      
Issuances under equity incentive plans 17,389 $ 13 17,376    
Vesting of restricted stock units (in shares)   1,302,190      
Vesting of restricted stock units 0 $ 12 (12)    
Stock-based compensation 103,484   103,484    
Net loss (422,773)       (422,773)
Other comprehensive income (loss) $ 1,377     1,377  
Ending balance (in shares) at Dec. 31, 2024 144,220,986 144,220,986      
Ending balance at Dec. 31, 2024 $ 1,229,684 $ 1,768 2,764,880 2,020 (1,538,984)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)   9,142,857      
Issuance of common stock and pre-funded warrants, net of issuance costs 189,249 $ 91 189,158    
Issuances under equity incentive plans (in shares)   1,368,573      
Issuances under equity incentive plans 8,459 $ 14 8,445    
Vesting of restricted stock units (in shares)   1,449,761      
Vesting of restricted stock units 0 $ 15 (15)    
Stock-based compensation 100,247   100,247    
Net loss (512,540)       (512,540)
Other comprehensive income (loss) $ (1,338)     (1,338)  
Ending balance (in shares) at Dec. 31, 2025 156,182,177 156,182,177      
Ending balance at Dec. 31, 2025 $ 1,013,761 $ 1,888 $ 3,062,715 $ 682 $ (2,051,524)